Beyond the Surface: Delving into Toxic Adulterants in the Opioid Crisis
The opioid use epidemic has been on the forefront of societal concerns in the US. With the DEA-MATE act, all providers must be able to adeptly prescribe and manage Opioid Use Disorder (OUD) and related issues, which have proliferated. Treating teams face multiple challenges including need to treat chronic pain, over prescription of opioids and need for effective alternatives, and illicit use of opioids. The focus of this conference is pharmacological, psychotherapeutic treatments of OUD along with overviews of impact on families and children. We are proud to involve multiple community organizations that provide substance use treatments so attendees can have a comprehensive view of how to get patients effective OUD treatments in and out of the medical system. A main goal for the attendees is to be empowered and confident to initiate and/or maintain treatments for OUD.
Target Audience
Physicians and advanced-practice providers in psychiatry, emergency medicine, family medicine, internal medicine, and obstetrics and gynecology and the community.
Learning Objectives
At the conclusion of the session, the participants should be able to:
- Describe the various adulterants commonly found in opioids and their associated risks.
- Review the motivations behind the adulteration of opioids.
- Identify clinical presentations that may suggest exposure to adulterants.
- Discuss and implement harm reduction strategies to reduce overdose from opioids and associated adulterants.
- Analyze the impact of opioid adulterants on the healthcare system.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Pain Management
- 0.50 Participation